Cases
Medidata Solutions, Inc. (NASDAQ: MDSO)
Merger
Overview
Overview
- Date:
- 6/12/2019
- Company Name:
- Medidata Solutions, Inc.
- Stock Symbol:
- MDSO
- Company Name - Buyer:
- Dassault Systèmes
- Stock Symbol - Buyer:
- DASTY
- Status:
- Closed/Complete
- Merger Announcement Date:
- 6/12/2019
NEW YORK, June 12, 2019 – Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Medidata Solutions, Inc (NASDAQ: MDSO) on behalf of Medidata shareholders concerning the proposed merger with Dassault Systèmes (Other OTC: DASTY).
Pursuant to the proposed transaction, announced on June 12, 2019 and valued at $5.8 billion, Medidata shareholders will receive $92.50 for each share of Medidata common stock owned. The investigation focuses on whether Medidata and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s shareholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own Medidata shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 308-1869, or by filling out the contact form below. There is no cost or obligation to you.
Pursuant to the proposed transaction, announced on June 12, 2019 and valued at $5.8 billion, Medidata shareholders will receive $92.50 for each share of Medidata common stock owned. The investigation focuses on whether Medidata and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s shareholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.
If you own Medidata shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 308-1869, or by filling out the contact form below. There is no cost or obligation to you.